| Name | N-[(E)-2-(2,5-dihydroxyphenyl)ethenyl]formamide |
|---|---|
| Synonyms |
N-[2-(2,5-dihydroxyphenyl)ethenyl]formamide
FORMAMIDE,N-(2-(2,5-DIHYDROXYPHENYL)ETHENYL)-,(E) (E)-N-(2-(2,5-Dihydroxyphenyl)ethenyl)formamide (2-formamidovinyl)-2,5-dihydroxybenzene Erbstatin |
| Description | Erbstatin, a EGFR kinase inhibitor, possesses antineoplastic effect[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Erbstatin不抑制EGF与其受体的结合,但是会抑制EGFR复合物的内吞作用,而且该化合物不会抑制A431细胞中EGF刺激的磷脂酰肌醇代谢[2]。 Erbstatin引起人小细胞肺癌(SCLC)细胞形态学凋亡和DNA断裂[3]。 |
| References |
| Density | 1.343g/cm3 |
|---|---|
| Boiling Point | 517.5ºC at 760mmHg |
| Molecular Formula | C9H9NO3 |
| Molecular Weight | 179.17 |
| Flash Point | 266.8ºC |
| Exact Mass | 179.05800 |
| PSA | 69.56000 |
| LogP | 1.84130 |
| Vapour Pressure | 2.48E-11mmHg at 25°C |
| Index of Refraction | 1.667 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Precursor 9 | |
|---|---|
| DownStream 0 | |